摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5‑(4‑nitrophenyl)‑2,8‑dithioxo‑2,3,7,8,9,10‑hexahydropyrido[2,3‑d:6,5‑d']dipyrimidine‑4,6(1H,5H)‑dione | 1219456-24-2

中文名称
——
中文别名
——
英文名称
5‑(4‑nitrophenyl)‑2,8‑dithioxo‑2,3,7,8,9,10‑hexahydropyrido[2,3‑d:6,5‑d']dipyrimidine‑4,6(1H,5H)‑dione
英文别名
5-(4-nitrophenyl)-2,8-dithioxo-2,3,7,8,9,10-hexahydropyrido[2,3-d:6,5-d′]dipyrimidine 4,6(1H,5H)-dione;5-(4-nitrophenyl)-2,8-dithioxo-2,3,7,8,9,10-hexahydropyrido[2,3-d:6,5-d']dipyrimidine-4,6(1H,5H)-dione;5-(4-nitrophenyl)-2,8-dithioxo-2,3,7,8,9,10-hexahydropyrido[2,3-d:6,5-d]dipyrimidine-4,6(1H,5H)-dione
5‑(4‑nitrophenyl)‑2,8‑dithioxo‑2,3,7,8,9,10‑hexahydropyrido[2,3‑d:6,5‑d']dipyrimidine‑4,6(1H,5H)‑dione化学式
CAS
1219456-24-2
化学式
C15H10N6O4S2
mdl
——
分子量
402.414
InChiKey
CJACKYKFKDJUSC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.32
  • 重原子数:
    27.0
  • 可旋转键数:
    2.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    152.47
  • 氢给体数:
    5.0
  • 氢受体数:
    7.0

反应信息

  • 作为产物:
    描述:
    6-氨基-2-硫脲嘧啶对硝基苯甲醛盐酸 作用下, 以 甲醇 为溶剂, 反应 4.0h, 以77%的产率得到5‑(4‑nitrophenyl)‑2,8‑dithioxo‑2,3,7,8,9,10‑hexahydropyrido[2,3‑d:6,5‑d']dipyrimidine‑4,6(1H,5H)‑dione
    参考文献:
    名称:
    合成某些作为抗菌剂和抗炎剂的嘧啶衍生物。
    摘要:
    通过6-氨基-2-硫代-1H-嘧啶-4-酮(1)与不同试剂反应得到多种新型双环和三环嘧啶衍生物。测试了一些合成化合物的抗菌和抗炎活性。
    DOI:
    10.3390/molecules15031882
点击查看最新优质反应信息

文献信息

  • Sonochemical synthesis of pyrido[2,3-d:6,5-d′]-dipyrimidines catalyzed by [HNMP]+[HSO4]− and their antimicrobial activity studies
    作者:Hossein Naeimi、Asieh Didar、Zahra Rashid、Zohreh Zahraie
    DOI:10.1038/ja.2017.47
    日期:2017.7
    [H-NMP]+[HSO4]- under ultrasonic irradiation in water is reported. In the present procedure, the pyrido[2,3-d:6,5-d']dipyrimidine derivatives were purely produced as valuable products. The process proved to be simple, environmentally friendly, efficient and high to excellent yielding. Moreover, some of the synthetic compounds were investigated and revealed important antimicrobial activity of prepared products
    在这项研究中,报告了在中超声催化下,在催化量的[H-NMP] + [HSO 4 ] -存在下,芳香醛,2-巴比妥酸乙酸铵的一锅四组分反应。在本方法中,吡啶并[2,3-d:6,5-d']双嘧啶生物纯粹作为有价值的产品生产。事实证明,该方法简单,环保,高效且产率高至优异。此外,对一些合成化合物进行了研究,发现所制得的产品具有重要的抗菌活性。
  • Microwave-assisted synthesis of pyrido-dipyrimidines using magnetically CuFe2O4 nanoparticles as an efficient, reusable, and powerful catalyst in water
    作者:Hossein Naeimi、Asieh Didar、Zahra Rashid
    DOI:10.1007/s13738-016-0986-8
    日期:2017.2
    AbstractAn efficient and direct procedure for the synthesis of pyrido[2,3-d:6,5-d′]dipyrimidine derivatives has been described under microwave-assisted conditions. The reaction of 2-thiobarbituric acid with aromatic aldehydes and ammonium acetate catalyzed by CuFe2O4 nanoparticles was resulted in the formation of pyrido[2,3-d:6,5 d′]dipyrimidine derivatives. The corresponding products have been obtained
    摘要已经描述了在微波辅助条件下合成吡啶并[2,3-d:6,5-d']双嘧啶生物的有效而直接的方法。CuFe 2 O 4纳米粒子催化2-巴比妥酸与芳族醛和乙酸铵的反应,形成吡啶并[2,3-d:6,5 d']双嘧啶生物。以优异的分离产率,高纯度,较短的反应时间和容易的后处理获得了相应的产物。 图形概要
  • Nano-2-(dimethylamino)-<i>N</i>-(silica-<i>n</i>-propyl)-<i>N</i>,<i>N</i>-dimethylethanaminium chloride as a novel basic catalyst for the efficient synthesis of pyrido[2,3-<i>d</i>:6,5-<i>d</i>′]dipyrimidines
    作者:Abdolkarim Zare、Alireza Kohzadian、Zahra Abshirini、Seyed Sajad Sajadikhah、Joshua Phipps、Mourad Benamara、M. Hassan Beyzavi
    DOI:10.1039/c8nj04921a
    日期:——

    A novel basic nanocatalyst has been synthesized, fully characterized, and applied to promote the efficient synthesis of pyrido[2,3-d:6,5-d′]dipyrimidines.

    一种新型基本纳米催化剂已经合成、完全表征,并应用于促进高效合成吡啶并[2,3-d:6,5-d′]二嘧啶
  • Efficient sonochemical green reaction of aldehyde, thiobarbituric acid and ammonium acetate using magnetically recyclable nanocatalyst in water
    作者:Hossein Naeimi、Asieh Didar
    DOI:10.1016/j.ultsonch.2016.07.021
    日期:2017.1
    facile one-pot and four-component economical synthesis of pyrido[2,3-d:6,5-d]dipyrimidines using aldehyde, 2-thiobarbituric acid and ammonium acetate in the presence of magnetically heterogeneous catalyst under ultrasonic irradiation in water is described. The present synthesis shows attractive characteristics such as; the use of magnetically recoverable and reusable catalyst, convenient one-pot operation
    在超声作用下,在中进行磁多相催化的情况下,使用醛,2-巴比妥酸乙酸铵,一种简便的一锅四组分经济合成吡啶并[2,3-d:6,5-d]双嘧啶的方法是描述。本发明的合成物显示出吸引人的特性,例如:使用磁性可回收和可重复使用的催化剂,方便的一锅操作,较短的反应时间,高到极好的收率以及使用作为绿色反应介质,温和的反应条件,被认为是相对环境友好的。
  • Facile one-pot four component synthesis of pyrido[2,3-d:6,5-d′]dipyrimidines catalyzed by CuFe 2 O 4 magnetic nanoparticles in water
    作者:Hossein Naeimi、Asieh Didar
    DOI:10.1016/j.molstruc.2017.02.044
    日期:2017.6
    Abstract A simple, efficient and green method for the synthesis of pyrido[2,3-d:6,5-d′]dipyrimidine derivatives via one-pot four-component reaction of aromatic aldehyde, 2-thiobarbituric acid, ammonium acetate in the presence of catalytic amount of a magnetically heterogeneous catalyst has been developed. This protocol includes some important advantages such as; high to excellent product yields, high
    摘要 一种以芳香醛、2-巴比妥酸醋酸为原料的一锅四组分反应合成吡啶并[2,3-d:6,5-d']二嘧啶生物的简便、高效、绿色的方法。已经开发了存在催化量的磁性非均相催化剂。该协议包括一些重要的优点,例如;高至优异的产品收率,高原子经济性,使用作为绿色反应介质,催化剂可重复使用,后处理程序简单。
查看更多

同类化合物

叔-丁基2-(甲磺酰)-5,7-二氢螺[吡喃并[4,3-D]嘧啶并-8,3-吡咯烷]-1-甲酸基酯 乙基7'-氨基-6-氟-2,2',4'-三羰基-1,1',2,2',3',4'-六氢螺[吲哚-3,5'-吡喃并[2,3-d]嘧啶]-6'-羧酸酯 7H-吡喃并[2,3-d]嘧啶-7-酮 7H-吡喃并[2,3-d]嘧啶 7,8-二氢-5H-吡喃并[4,3-D]嘧啶-2-胺 5H-吡喃并[4,3-d]嘧啶 5H-吡喃并[2,3-d]嘧啶 2H-吡喃并[2,3-d]嘧啶-6-甲腈,7-氨基-1,3,4,5-四氢-5-(4-甲氧苯基)-2,4-二羰基- 2,4-二氯-7,8-二氢-5H-吡喃[4,3-d]嘧啶 1H-吡喃并[3,4-d]嘧啶 1H-吡喃并[3,2-d]嘧啶 (5S,7R,8S)-2-methylsulfanyl-5,8-dihydro-7-allyloxymethyl-5-methoxy-pyrano[3,4-d]-pyrimidin-8-ol 5-ethyl-2-[(Z)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-ethyl-2-[[1-(3-methylbutanoyl)piperidin-4-ylidene]amino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-butyl-2-[(E)-1-(4-cyclohexylpiperazin-1-yl)butylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 2,3,3a,9-tetrahydro-5-iodo-2,3,3-trimethylimidazo[5,1-b][1,3]benzoxazin-1-one 2,4-dimethyl-9-methoxy-4,12b-dihydro-1H,7H-chromeno[4',3'-4,5]pyrano[2,3-d]pyrimidine-1,3(2H)-dione 5-methyl-3-{3-[(R)-2-oxo-3-(3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)-oxazolidin-5-yl]-propyl}-1H-quinazoline-2,4-dione 7-amino-2-(benzothiazol-2-ylmethyl)-9-phenylthiazolo[4',5':6,5]pyrano[2,3-d]pyrimidine-8(7H)-one 2-[6-[(2-chlorophenyl)methyl]pyridin-2-yl]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidine 8-amino-2-(methylthio)-5-oxo-6-(pyridin-4-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 5-(4-chlorophenyl)-1,3,8,8-tetramethyl-7,9-dihydro-5H-chromeno[2,3-d]pyrimidine-2,4,6-trione ethyl 7'-amino-2,4'-dioxo-2'-thioxo-1,1',2,2',3',4'-hexahydrospiroindole-3,5'-pyrano[2,3-d]pyrimidine-6'-carboxylate 8-amino-2-(methylthio)-5-oxo-6-(pyridin-3-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 7-Amino-4-oxo-5-phenyl-2-thioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylic acid ethyl ester 3-(1H-benzoimidazol-2-yl)-3-butyl-5-methyl-dihydro-furan-2-one 3-(1H-benzoimidazol-2-yl)-3-(2-diethylamino-ethyl)-5-methyl-dihydro-furan-2-one 1-{4-[(1R,9S)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea (S)-6-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyridin-2(1H)-one 3-(1H-benzoimidazol-2-yl)-5-methyl-3-(3-methyl-butyl)-dihydro-furan-2-one 13-(3,4-dimethoxyphenyl)-5,5-dimethyl-2-thioxo-2,5,6,8,9,13-hexahydro-4H-pyrimido[5',4':6,7][1,8]naphthyridino[4,3,2-de]quinazoline-10,12(3a1H,11H)-dione (S)-3-allyl-8-ethyl-4,7-dioxo-2-(phenylcarbamoyl)-4,5,7,8-tetrahydro-3H-pyrano[4,3-d]pyrimidin-8-yl acetate 8-{[(2-bromo-3-methylphenyl)oxy]methyl}-1,3-dimethyl-2,3,4,6-tetrahydro-1H-pyrano[3,2-d]pyrimidine-2,4-dione 9-ethyl-6a-methyl-2-phenyl-8,9-dihydro-oxazolo[2,3-b]pyrimido[4,5-d][1,3]oxazin-5-one (S)-1-cyclobutyl-3-(4-(4-(3-methylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenyl)urea (S)-2-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyrimidin-4(3H)-one (6aRS,10aRS)-4,6,6a,7,8,9,10,10a-octahydro-2,4,6,6-tetramethyl-1H-<2>benzopyrano<3,4-d>pyrimidine-1,3(2H)-dione 5-ethyl-2-[(E)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione N3-(methyl 4-deoxy-α-L-threo-hex-4-enopyranosyluronate)-5-fluorouracil 1-{4-[(1S,9R)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea 4,5-dimethyl-12-(4-methoxyphenyl)-2-thioxo-2,4a,7,8,9,10,11,12-octahydrodipyrimido[4,5-b;4',5'-f] [1,8]naphthyridine-9,11-dione 2-[4-[2-hydroxyethyl(methyl)amino]-2-methyl-7-oxopyrimido[5,4-b][1,4]oxazin-8-yl]acetonitrile 5-ethyl-2-[(Z)-1-thiophen-2-ylethylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione